Trial Outcomes & Findings for Team-Based Connected Health (TCH) to Improve Clinical Outcomes and Access in Atopic Dermatitis (NCT NCT03981926)
NCT ID: NCT03981926
Last Updated: 2025-10-06
Results Overview
EASI combines the assessment of disease severity (erythema, induration, excoriation, and lichenification) and the affected area into a single score between 0 (no disease) to 72 (maximal disease). The primary outcome of the study is the mean improvement in EASI.
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
300 participants
Primary outcome timeframe
12 months
Results posted on
2025-10-06
Participant Flow
Participant milestones
| Measure |
In-Person
In-person care is the control group because it is currently considered the standard of care in delivering dermatologic services. The intervention includes regular visits to a physician, and may include such treatments as ointments, steroids or ultraviolet therapy at the discretion of a physician. In-person care is the major healthcare-delivery model for managing chronic skin diseases and a realistic, primary option that patients face. The patients in the in-person arm can seek atopic dermatitis care from primary care practitioners or dermatologists, just as they would in the real world.
|
Team-Based Connected Health (TCH)
The intervention arm is the team-based connected health (TCH) model, which purports to increase access to specialists and improve outcomes. Specifically, TCH offers multiple modalities for patients and primary care providers (PCPs) to access dermatologists online directly and asynchronously. TCH also fosters team care and patient engagement through active sharing of management plans and multidirectional, informed communication among patients, PCPs, and dermatologists.
Team-Based Connected Health (TCH): TCH is an asynchronous, secure online platform where patients can upload images of atopic dermatitis disease and submit assessments. Likewise, practitioners can request and/or initiate dermatology consultations, assume longitudinal care or communicate with patients directly.
|
|---|---|---|
|
Overall Study
STARTED
|
151
|
149
|
|
Overall Study
COMPLETED
|
146
|
140
|
|
Overall Study
NOT COMPLETED
|
5
|
9
|
Reasons for withdrawal
| Measure |
In-Person
In-person care is the control group because it is currently considered the standard of care in delivering dermatologic services. The intervention includes regular visits to a physician, and may include such treatments as ointments, steroids or ultraviolet therapy at the discretion of a physician. In-person care is the major healthcare-delivery model for managing chronic skin diseases and a realistic, primary option that patients face. The patients in the in-person arm can seek atopic dermatitis care from primary care practitioners or dermatologists, just as they would in the real world.
|
Team-Based Connected Health (TCH)
The intervention arm is the team-based connected health (TCH) model, which purports to increase access to specialists and improve outcomes. Specifically, TCH offers multiple modalities for patients and primary care providers (PCPs) to access dermatologists online directly and asynchronously. TCH also fosters team care and patient engagement through active sharing of management plans and multidirectional, informed communication among patients, PCPs, and dermatologists.
Team-Based Connected Health (TCH): TCH is an asynchronous, secure online platform where patients can upload images of atopic dermatitis disease and submit assessments. Likewise, practitioners can request and/or initiate dermatology consultations, assume longitudinal care or communicate with patients directly.
|
|---|---|---|
|
Overall Study
Lost to Follow-up
|
5
|
9
|
Baseline Characteristics
Team-Based Connected Health (TCH) to Improve Clinical Outcomes and Access in Atopic Dermatitis
Baseline characteristics by cohort
| Measure |
In-Person
n=151 Participants
In-person care is the control group because it is currently considered the standard of care in delivering dermatologic services. The intervention includes regular visits to a physician, and may include such treatments as ointments, steroids or ultraviolet therapy at the discretion of a physician. In-person care is the major healthcare-delivery model for managing chronic skin diseases and a realistic, primary option that patients face. The patients in the in-person arm can seek atopic dermatitis care from primary care practitioners or dermatologists, just as they would in the real world.
|
Team-Based Connected Health (TCH)
n=149 Participants
The intervention arm is the team-based connected health (TCH) model, which purports to increase access to specialists and improve outcomes. Specifically, TCH offers multiple modalities for patients and primary care providers (PCPs) to access dermatologists online directly and asynchronously. TCH also fosters team care and patient engagement through active sharing of management plans and multidirectional, informed communication among patients, PCPs, and dermatologists.
Team-Based Connected Health (TCH): TCH is an asynchronous, secure online platform where patients can upload images of atopic dermatitis disease and submit assessments. Likewise, practitioners can request and/or initiate dermatology consultations, assume longitudinal care or communicate with patients directly.
|
Total
n=300 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
32.1 years
STANDARD_DEVIATION 16.6 • n=99 Participants
|
37.2 years
STANDARD_DEVIATION 18.2 • n=107 Participants
|
34.6 years
STANDARD_DEVIATION 17.7 • n=206 Participants
|
|
Sex: Female, Male
Female
|
106 Participants
n=99 Participants
|
105 Participants
n=107 Participants
|
211 Participants
n=206 Participants
|
|
Sex: Female, Male
Male
|
45 Participants
n=99 Participants
|
44 Participants
n=107 Participants
|
89 Participants
n=206 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
39 Participants
n=99 Participants
|
47 Participants
n=107 Participants
|
86 Participants
n=206 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
110 Participants
n=99 Participants
|
102 Participants
n=107 Participants
|
212 Participants
n=206 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
2 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
2 Participants
n=206 Participants
|
|
Race/Ethnicity, Customized
American Indian or Alaskan Native
|
1 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
1 Participants
n=206 Participants
|
|
Race/Ethnicity, Customized
Asian
|
65 Participants
n=99 Participants
|
47 Participants
n=107 Participants
|
112 Participants
n=206 Participants
|
|
Race/Ethnicity, Customized
Black or African American
|
12 Participants
n=99 Participants
|
15 Participants
n=107 Participants
|
27 Participants
n=206 Participants
|
|
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=99 Participants
|
1 Participants
n=107 Participants
|
1 Participants
n=206 Participants
|
|
Race/Ethnicity, Customized
White
|
53 Participants
n=99 Participants
|
63 Participants
n=107 Participants
|
116 Participants
n=206 Participants
|
|
Race/Ethnicity, Customized
Other
|
20 Participants
n=99 Participants
|
23 Participants
n=107 Participants
|
43 Participants
n=206 Participants
|
|
Education
Grades 1-8 (Grade School)
|
10 Participants
n=99 Participants
|
11 Participants
n=107 Participants
|
21 Participants
n=206 Participants
|
|
Education
Some High School
|
5 Participants
n=99 Participants
|
5 Participants
n=107 Participants
|
10 Participants
n=206 Participants
|
|
Education
High School Diploma or Equivalent (GED)
|
7 Participants
n=99 Participants
|
8 Participants
n=107 Participants
|
15 Participants
n=206 Participants
|
|
Education
Some College, No Degree
|
26 Participants
n=99 Participants
|
33 Participants
n=107 Participants
|
59 Participants
n=206 Participants
|
|
Education
College Degree
|
49 Participants
n=99 Participants
|
54 Participants
n=107 Participants
|
103 Participants
n=206 Participants
|
|
Education
Graduate or Doctoral Degree
|
35 Participants
n=99 Participants
|
32 Participants
n=107 Participants
|
67 Participants
n=206 Participants
|
|
Education
Not Applicable
|
18 Participants
n=99 Participants
|
6 Participants
n=107 Participants
|
24 Participants
n=206 Participants
|
|
Education
Unknown or Not Reported
|
1 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
1 Participants
n=206 Participants
|
|
Insurance Type
Private or Health Maintenance Organization (HMO)
|
111 Participants
n=99 Participants
|
99 Participants
n=107 Participants
|
210 Participants
n=206 Participants
|
|
Insurance Type
Medicaid
|
20 Participants
n=99 Participants
|
22 Participants
n=107 Participants
|
42 Participants
n=206 Participants
|
|
Insurance Type
Medicare
|
12 Participants
n=99 Participants
|
20 Participants
n=107 Participants
|
32 Participants
n=206 Participants
|
|
Insurance Type
No Insurance
|
5 Participants
n=99 Participants
|
7 Participants
n=107 Participants
|
12 Participants
n=206 Participants
|
|
Insurance Type
Unknown or Not Reported
|
3 Participants
n=99 Participants
|
1 Participants
n=107 Participants
|
4 Participants
n=206 Participants
|
PRIMARY outcome
Timeframe: 12 monthsEASI combines the assessment of disease severity (erythema, induration, excoriation, and lichenification) and the affected area into a single score between 0 (no disease) to 72 (maximal disease). The primary outcome of the study is the mean improvement in EASI.
Outcome measures
| Measure |
In-Person
n=151 Participants
In-person care is the control group because it is currently considered the standard of care in delivering dermatologic services. The intervention includes regular visits to a physician, and may include such treatments as ointments, steroids or ultraviolet therapy at the discretion of a physician. In-person care is the major healthcare-delivery model for managing chronic skin diseases and a realistic, primary option that patients face. The patients in the in-person arm can seek atopic dermatitis care from primary care practitioners or dermatologists, just as they would in the real world.
|
Team-Based Connected Health (TCH)
n=149 Participants
The intervention arm is the team-based connected health (TCH) model, which purports to increase access to specialists and improve outcomes. Specifically, TCH offers multiple modalities for patients and primary care providers (PCPs) to access dermatologists online directly and asynchronously. TCH also fosters team care and patient engagement through active sharing of management plans and multidirectional, informed communication among patients, PCPs, and dermatologists.
Team-Based Connected Health (TCH): TCH is an asynchronous, secure online platform where patients can upload images of atopic dermatitis disease and submit assessments. Likewise, practitioners can request and/or initiate dermatology consultations, assume longitudinal care or communicate with patients directly.
|
|---|---|---|
|
Change in Disease Severity as Measured by the Eczema Area and Severity Index (EASI)
Baseline
|
4.81 score on a scale
Interval 4.04 to 5.59
|
4.93 score on a scale
Interval 3.9 to 5.95
|
|
Change in Disease Severity as Measured by the Eczema Area and Severity Index (EASI)
Month 12
|
2.70 score on a scale
Interval 1.97 to 3.43
|
2.76 score on a scale
Interval 2.16 to 3.35
|
SECONDARY outcome
Timeframe: 12 monthsvIGA is an ordinal scale that provides a global assessment of the patient's AD disease severity. vIGA is scored on a 5-point ordinal scale ranging from 0 (clear) to 4 (severe). The overall change in disease severity for this outcome is measured by calculating the change in vIGA score from baseline averaged across 12 months.
Outcome measures
| Measure |
In-Person
n=151 Participants
In-person care is the control group because it is currently considered the standard of care in delivering dermatologic services. The intervention includes regular visits to a physician, and may include such treatments as ointments, steroids or ultraviolet therapy at the discretion of a physician. In-person care is the major healthcare-delivery model for managing chronic skin diseases and a realistic, primary option that patients face. The patients in the in-person arm can seek atopic dermatitis care from primary care practitioners or dermatologists, just as they would in the real world.
|
Team-Based Connected Health (TCH)
n=149 Participants
The intervention arm is the team-based connected health (TCH) model, which purports to increase access to specialists and improve outcomes. Specifically, TCH offers multiple modalities for patients and primary care providers (PCPs) to access dermatologists online directly and asynchronously. TCH also fosters team care and patient engagement through active sharing of management plans and multidirectional, informed communication among patients, PCPs, and dermatologists.
Team-Based Connected Health (TCH): TCH is an asynchronous, secure online platform where patients can upload images of atopic dermatitis disease and submit assessments. Likewise, practitioners can request and/or initiate dermatology consultations, assume longitudinal care or communicate with patients directly.
|
|---|---|---|
|
Change in Disease Severity as Measured by the Validated Investigator Global Assessment (vIGA)
Baseline
|
2.28 score on a scale
Interval 2.12 to 2.45
|
2.48 score on a scale
Interval 2.3 to 2.65
|
|
Change in Disease Severity as Measured by the Validated Investigator Global Assessment (vIGA)
Month 12
|
1.71 score on a scale
Interval 1.55 to 1.86
|
1.56 score on a scale
Interval 1.39 to 1.73
|
SECONDARY outcome
Timeframe: 12 monthsPOEM is a 7-item tool for patient and/or proxy self-completion used to monitor atopic dermatitis severity, focusing on the illness as experienced by the patient. Scores range from 0 (clear) to 28 (very severe). The overall change in disease severity for this outcome will be measured by calculating the change in POEM score from baseline averaged across 12 months.
Outcome measures
| Measure |
In-Person
n=151 Participants
In-person care is the control group because it is currently considered the standard of care in delivering dermatologic services. The intervention includes regular visits to a physician, and may include such treatments as ointments, steroids or ultraviolet therapy at the discretion of a physician. In-person care is the major healthcare-delivery model for managing chronic skin diseases and a realistic, primary option that patients face. The patients in the in-person arm can seek atopic dermatitis care from primary care practitioners or dermatologists, just as they would in the real world.
|
Team-Based Connected Health (TCH)
n=149 Participants
The intervention arm is the team-based connected health (TCH) model, which purports to increase access to specialists and improve outcomes. Specifically, TCH offers multiple modalities for patients and primary care providers (PCPs) to access dermatologists online directly and asynchronously. TCH also fosters team care and patient engagement through active sharing of management plans and multidirectional, informed communication among patients, PCPs, and dermatologists.
Team-Based Connected Health (TCH): TCH is an asynchronous, secure online platform where patients can upload images of atopic dermatitis disease and submit assessments. Likewise, practitioners can request and/or initiate dermatology consultations, assume longitudinal care or communicate with patients directly.
|
|---|---|---|
|
Change in Disease Severity as Measured by the Patient-Oriented Eczema Measure (POEM).
Baseline
|
11.7 score on a scale
Interval 10.5 to 12.9
|
11.6 score on a scale
Interval 10.5 to 12.8
|
|
Change in Disease Severity as Measured by the Patient-Oriented Eczema Measure (POEM).
Month 12
|
8.57 score on a scale
Interval 7.55 to 9.59
|
7.70 score on a scale
Interval 6.65 to 8.74
|
SECONDARY outcome
Timeframe: 12 monthsThe DLQI and the CDLQI are validated, 10-question questionnaires that can be used to assess dermatology-specific quality of life in adults and children with atopic dermatitis. Scores range from 0 to 30, with higher scores indicating more severe impact on quality of life. The overall change in quality of life for this outcome is measured by calculating the change in DLQI / CDLQI from baseline averaged across 12 months.
Outcome measures
| Measure |
In-Person
n=151 Participants
In-person care is the control group because it is currently considered the standard of care in delivering dermatologic services. The intervention includes regular visits to a physician, and may include such treatments as ointments, steroids or ultraviolet therapy at the discretion of a physician. In-person care is the major healthcare-delivery model for managing chronic skin diseases and a realistic, primary option that patients face. The patients in the in-person arm can seek atopic dermatitis care from primary care practitioners or dermatologists, just as they would in the real world.
|
Team-Based Connected Health (TCH)
n=149 Participants
The intervention arm is the team-based connected health (TCH) model, which purports to increase access to specialists and improve outcomes. Specifically, TCH offers multiple modalities for patients and primary care providers (PCPs) to access dermatologists online directly and asynchronously. TCH also fosters team care and patient engagement through active sharing of management plans and multidirectional, informed communication among patients, PCPs, and dermatologists.
Team-Based Connected Health (TCH): TCH is an asynchronous, secure online platform where patients can upload images of atopic dermatitis disease and submit assessments. Likewise, practitioners can request and/or initiate dermatology consultations, assume longitudinal care or communicate with patients directly.
|
|---|---|---|
|
Change in Quality of Life as Measured by the Dermatology Life Quality Index (DLQI) and the Children's Dermatology Quality Index (CDLQI)
Baseline
|
7.73 score on a scale
Interval 6.73 to 8.73
|
8.04 score on a scale
Interval 7.0 to 9.08
|
|
Change in Quality of Life as Measured by the Dermatology Life Quality Index (DLQI) and the Children's Dermatology Quality Index (CDLQI)
Month 12
|
6.52 score on a scale
Interval 5.46 to 7.58
|
6.10 score on a scale
Interval 5.03 to 7.17
|
SECONDARY outcome
Timeframe: 12 monthsEQ-5D-5L and EQ-5D-Y are validated measures of health status. The EQ-5D-5L and the EQ-5D-Y provide an index value that can be used for quality of life and economic evaluations. An index value of 0 represents a health state equivalent to death and an index value of 1 represents full health. The EQ-5D-5L and the EQ-5D-Y also provide a Visual Analogue Score (VAS) where respondents rate their perceived health from 0 (worst imaginable health) to 100 (best imaginable health). The overall change in quality of life for this outcome is measured by calculating the change in utility index and VAS from baseline averaged across 12 months.
Outcome measures
| Measure |
In-Person
n=151 Participants
In-person care is the control group because it is currently considered the standard of care in delivering dermatologic services. The intervention includes regular visits to a physician, and may include such treatments as ointments, steroids or ultraviolet therapy at the discretion of a physician. In-person care is the major healthcare-delivery model for managing chronic skin diseases and a realistic, primary option that patients face. The patients in the in-person arm can seek atopic dermatitis care from primary care practitioners or dermatologists, just as they would in the real world.
|
Team-Based Connected Health (TCH)
n=149 Participants
The intervention arm is the team-based connected health (TCH) model, which purports to increase access to specialists and improve outcomes. Specifically, TCH offers multiple modalities for patients and primary care providers (PCPs) to access dermatologists online directly and asynchronously. TCH also fosters team care and patient engagement through active sharing of management plans and multidirectional, informed communication among patients, PCPs, and dermatologists.
Team-Based Connected Health (TCH): TCH is an asynchronous, secure online platform where patients can upload images of atopic dermatitis disease and submit assessments. Likewise, practitioners can request and/or initiate dermatology consultations, assume longitudinal care or communicate with patients directly.
|
|---|---|---|
|
Change in Quality of Life as Measured by the EQ-5D-5L and the EQ-5D-Y
Utility Index Baseline
|
0.86 score on a scale
Interval 0.83 to 0.89
|
0.85 score on a scale
Interval 0.82 to 0.88
|
|
Change in Quality of Life as Measured by the EQ-5D-5L and the EQ-5D-Y
Utility Index Month 12
|
0.87 score on a scale
Interval 0.84 to 0.91
|
0.87 score on a scale
Interval 0.84 to 0.9
|
|
Change in Quality of Life as Measured by the EQ-5D-5L and the EQ-5D-Y
VAS Baseline
|
82.6 score on a scale
Interval 80.2 to 84.9
|
82.0 score on a scale
Interval 80.0 to 84.1
|
|
Change in Quality of Life as Measured by the EQ-5D-5L and the EQ-5D-Y
VAS Month 12
|
84.2 score on a scale
Interval 82.3 to 86.2
|
84.4 score on a scale
Interval 82.3 to 86.4
|
SECONDARY outcome
Timeframe: 12 monthsAccess-to-care measures include mode of transportation.
Outcome measures
| Measure |
In-Person
n=151 Participants
In-person care is the control group because it is currently considered the standard of care in delivering dermatologic services. The intervention includes regular visits to a physician, and may include such treatments as ointments, steroids or ultraviolet therapy at the discretion of a physician. In-person care is the major healthcare-delivery model for managing chronic skin diseases and a realistic, primary option that patients face. The patients in the in-person arm can seek atopic dermatitis care from primary care practitioners or dermatologists, just as they would in the real world.
|
Team-Based Connected Health (TCH)
n=149 Participants
The intervention arm is the team-based connected health (TCH) model, which purports to increase access to specialists and improve outcomes. Specifically, TCH offers multiple modalities for patients and primary care providers (PCPs) to access dermatologists online directly and asynchronously. TCH also fosters team care and patient engagement through active sharing of management plans and multidirectional, informed communication among patients, PCPs, and dermatologists.
Team-Based Connected Health (TCH): TCH is an asynchronous, secure online platform where patients can upload images of atopic dermatitis disease and submit assessments. Likewise, practitioners can request and/or initiate dermatology consultations, assume longitudinal care or communicate with patients directly.
|
|---|---|---|
|
Access to Care: Transportation
Bus or Train
|
12 Participants
|
9 Participants
|
|
Access to Care: Transportation
Car
|
131 Participants
|
139 Participants
|
|
Access to Care: Transportation
Walking
|
7 Participants
|
1 Participants
|
|
Access to Care: Transportation
Unknown or Not Reported
|
1 Participants
|
0 Participants
|
SECONDARY outcome
Timeframe: 12 monthsAccess-to-care measures include time needed for evaluation.
Outcome measures
| Measure |
In-Person
n=151 Participants
In-person care is the control group because it is currently considered the standard of care in delivering dermatologic services. The intervention includes regular visits to a physician, and may include such treatments as ointments, steroids or ultraviolet therapy at the discretion of a physician. In-person care is the major healthcare-delivery model for managing chronic skin diseases and a realistic, primary option that patients face. The patients in the in-person arm can seek atopic dermatitis care from primary care practitioners or dermatologists, just as they would in the real world.
|
Team-Based Connected Health (TCH)
n=149 Participants
The intervention arm is the team-based connected health (TCH) model, which purports to increase access to specialists and improve outcomes. Specifically, TCH offers multiple modalities for patients and primary care providers (PCPs) to access dermatologists online directly and asynchronously. TCH also fosters team care and patient engagement through active sharing of management plans and multidirectional, informed communication among patients, PCPs, and dermatologists.
Team-Based Connected Health (TCH): TCH is an asynchronous, secure online platform where patients can upload images of atopic dermatitis disease and submit assessments. Likewise, practitioners can request and/or initiate dermatology consultations, assume longitudinal care or communicate with patients directly.
|
|---|---|---|
|
Access to Care: Wait Time
Baseline
|
65.9 minutes
Standard Deviation 46.1
|
51.6 minutes
Standard Deviation 39.4
|
|
Access to Care: Wait Time
Month 12
|
30.1 minutes
Standard Deviation 33.1
|
29.1 minutes
Standard Deviation 30.0
|
SECONDARY outcome
Timeframe: 12 monthsWe will compare differences in healthcare utilization by using the Cornell Services Index (CSI). The CSI is a validated method to assess health service use. Mean time per medical, psychological, and professional visits will be calculated.
Outcome measures
| Measure |
In-Person
n=151 Participants
In-person care is the control group because it is currently considered the standard of care in delivering dermatologic services. The intervention includes regular visits to a physician, and may include such treatments as ointments, steroids or ultraviolet therapy at the discretion of a physician. In-person care is the major healthcare-delivery model for managing chronic skin diseases and a realistic, primary option that patients face. The patients in the in-person arm can seek atopic dermatitis care from primary care practitioners or dermatologists, just as they would in the real world.
|
Team-Based Connected Health (TCH)
n=149 Participants
The intervention arm is the team-based connected health (TCH) model, which purports to increase access to specialists and improve outcomes. Specifically, TCH offers multiple modalities for patients and primary care providers (PCPs) to access dermatologists online directly and asynchronously. TCH also fosters team care and patient engagement through active sharing of management plans and multidirectional, informed communication among patients, PCPs, and dermatologists.
Team-Based Connected Health (TCH): TCH is an asynchronous, secure online platform where patients can upload images of atopic dermatitis disease and submit assessments. Likewise, practitioners can request and/or initiate dermatology consultations, assume longitudinal care or communicate with patients directly.
|
|---|---|---|
|
Change in Healthcare Utilization and Healthcare Costs: Healthcare Utilization
Time per Medical Visit
|
44.6 minutes
Standard Deviation 45.2
|
46.0 minutes
Standard Deviation 38.1
|
|
Change in Healthcare Utilization and Healthcare Costs: Healthcare Utilization
Time per Psychological Visit
|
51.1 minutes
Standard Deviation 13.3
|
45.5 minutes
Standard Deviation 14.5
|
|
Change in Healthcare Utilization and Healthcare Costs: Healthcare Utilization
Time per Professional Visit
|
38.1 minutes
Standard Deviation 22.4
|
36.7 minutes
Standard Deviation 20.8
|
SECONDARY outcome
Timeframe: 12 monthsWe will compare differences in healthcare costs by using the Cornell Services Index (CSI). The CSI is a validated method to assess health service use. Mean out-of-pocket costs across medical, psychological, and professional visits will be calculated.
Outcome measures
| Measure |
In-Person
n=151 Participants
In-person care is the control group because it is currently considered the standard of care in delivering dermatologic services. The intervention includes regular visits to a physician, and may include such treatments as ointments, steroids or ultraviolet therapy at the discretion of a physician. In-person care is the major healthcare-delivery model for managing chronic skin diseases and a realistic, primary option that patients face. The patients in the in-person arm can seek atopic dermatitis care from primary care practitioners or dermatologists, just as they would in the real world.
|
Team-Based Connected Health (TCH)
n=149 Participants
The intervention arm is the team-based connected health (TCH) model, which purports to increase access to specialists and improve outcomes. Specifically, TCH offers multiple modalities for patients and primary care providers (PCPs) to access dermatologists online directly and asynchronously. TCH also fosters team care and patient engagement through active sharing of management plans and multidirectional, informed communication among patients, PCPs, and dermatologists.
Team-Based Connected Health (TCH): TCH is an asynchronous, secure online platform where patients can upload images of atopic dermatitis disease and submit assessments. Likewise, practitioners can request and/or initiate dermatology consultations, assume longitudinal care or communicate with patients directly.
|
|---|---|---|
|
Change in Healthcare Utilization and Healthcare Costs: Healthcare Costs
|
201.7 dollars
Standard Deviation 701
|
48.3 dollars
Standard Deviation 45
|
Adverse Events
In-Person
Serious events: 2 serious events
Other events: 0 other events
Deaths: 0 deaths
Team-Based Connected Health (TCH)
Serious events: 1 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
| Measure |
In-Person
n=151 participants at risk
In-person care is the control group because it is currently considered the standard of care in delivering dermatologic services. The intervention includes regular visits to a physician, and may include such treatments as ointments, steroids or ultraviolet therapy at the discretion of a physician. In-person care is the major healthcare-delivery model for managing chronic skin diseases and a realistic, primary option that patients face. The patients in the in-person arm can seek atopic dermatitis care from primary care practitioners or dermatologists, just as they would in the real world.
|
Team-Based Connected Health (TCH)
n=149 participants at risk
The intervention arm is the team-based connected health (TCH) model, which purports to increase access to specialists and improve outcomes. Specifically, TCH offers multiple modalities for patients and primary care providers (PCPs) to access dermatologists online directly and asynchronously. TCH also fosters team care and patient engagement through active sharing of management plans and multidirectional, informed communication among patients, PCPs, and dermatologists.
Team-Based Connected Health (TCH): TCH is an asynchronous, secure online platform where patients can upload images of atopic dermatitis disease and submit assessments. Likewise, practitioners can request and/or initiate dermatology consultations, assume longitudinal care or communicate with patients directly.
|
|---|---|---|
|
Gastrointestinal disorders
Biliary acute pancreatitis
|
0.66%
1/151 • 12 months
|
0.00%
0/149 • 12 months
|
|
Immune system disorders
Anaphylaxis
|
0.00%
0/151 • 12 months
|
0.67%
1/149 • 12 months
|
|
Musculoskeletal and connective tissue disorders
Tibia fracture
|
0.66%
1/151 • 12 months
|
0.00%
0/149 • 12 months
|
Other adverse events
Adverse event data not reported
Additional Information
April W. Armstrong, MD, MPH; Professor and Chief of Dermatology
University of California, Los Angeles
Phone: 424-365-4129
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place